A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. [electronic resource]
Producer: 20120313Description: 210-5 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Benzoquinones -- administration & dosage
- Biomarkers, Tumor -- metabolism
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Cohort Studies
- Deoxycytidine -- administration & dosage
- Female
- HSP70 Heat-Shock Proteins -- metabolism
- HSP90 Heat-Shock Proteins -- metabolism
- Humans
- Lactams, Macrocyclic -- administration & dosage
- Middle Aged
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Survival Rate
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.